Next Article in Journal
Mouse Cardiac Pde1C Is a Direct Transcriptional Target of Pparα
Next Article in Special Issue
Epigenetic Factors in Late-Onset Alzheimer’s Disease: MTHFR and CTH Gene Polymorphisms, Metabolic Transsulfuration and Methylation Pathways, and B Vitamins
Previous Article in Journal
Fish, Fish Oils and Cardioprotection: Promise or Fish Tale?
Previous Article in Special Issue
miRNA-34c Overexpression Causes Dendritic Loss and Memory Decline

Imaging and Molecular Mechanisms of Alzheimer’s Disease: A Review

Neurology Imaging Unit, Imperial College London, London W12 0NN, UK
Imperial Memory Unit, Charing Cross Hospital, Imperial College London, London W6 8RF, UK
Department of Medicine and Health Sciences, University of Molise, 86100 Campobasso, Italy
Department of Translational Medical Sciences, Federico II University of Naples, 80131 Naples, Italy
Istituti Clinici Scientifici Maugeri SPA—Società Benefit, IRCCS, 82037 Telese Terme, Italy
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(12), 3702;
Received: 5 October 2018 / Revised: 13 November 2018 / Accepted: 14 November 2018 / Published: 22 November 2018
(This article belongs to the Special Issue Molecular Mechanism of Alzheimer's Disease)
Alzheimer’s disease is the most common form of dementia and is a significant burden for affected patients, carers, and health systems. Great advances have been made in understanding its pathophysiology, to a point that we are moving from a purely clinical diagnosis to a biological one based on the use of biomarkers. Among those, imaging biomarkers are invaluable in Alzheimer’s, as they provide an in vivo window to the pathological processes occurring in Alzheimer’s brain. While some imaging techniques are still under evaluation in the research setting, some have reached widespread clinical use. In this review, we provide an overview of the most commonly used imaging biomarkers in Alzheimer’s disease, from molecular PET imaging to structural MRI, emphasising the concept that multimodal imaging would likely prove to be the optimal tool in the future of Alzheimer’s research and clinical practice. View Full-Text
Keywords: Alzheimer’s disease; positron emission tomography (PET); magnetic resonance imaging (MRI) Alzheimer’s disease; positron emission tomography (PET); magnetic resonance imaging (MRI)
Show Figures

Figure 1

MDPI and ACS Style

Femminella, G.D.; Thayanandan, T.; Calsolaro, V.; Komici, K.; Rengo, G.; Corbi, G.; Ferrara, N. Imaging and Molecular Mechanisms of Alzheimer’s Disease: A Review. Int. J. Mol. Sci. 2018, 19, 3702.

AMA Style

Femminella GD, Thayanandan T, Calsolaro V, Komici K, Rengo G, Corbi G, Ferrara N. Imaging and Molecular Mechanisms of Alzheimer’s Disease: A Review. International Journal of Molecular Sciences. 2018; 19(12):3702.

Chicago/Turabian Style

Femminella, Grazia D., Tony Thayanandan, Valeria Calsolaro, Klara Komici, Giuseppe Rengo, Graziamaria Corbi, and Nicola Ferrara. 2018. "Imaging and Molecular Mechanisms of Alzheimer’s Disease: A Review" International Journal of Molecular Sciences 19, no. 12: 3702.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop